Global Phage Therapy Market

Report ID : 1094 | Published : 2021-07-23 | Pages: 140 | Format: PDF/EXCEL

Phage therapy industry is experiencing huge research and development activities to develop products for different diseases and applications.The global phage therapy market is under development with no FDA-approved products. In the current scenario, natural phage-based products and compassionate phage therapy (CPT) are available in the market, which comprises current market revenue. Players such as Microgen (Russia), Duopharm (Germany), SES DERMA (Peru), BIOMED PERM NPO (Russia), and Phage Therapy Center are offering treatment for patients with chronic infectious diseases. However, the global phage therapy market has a tremendous opportunity to grow during the forecast period. The global phage therapy market size is expected to reach US$ 116.6 million by 2028, growing at a CAGR of 18.9% over the forecast period. By region, Europe dominates the market with a share of 57.0% of the global phage therapy market. Russia and Germany are the key markets holding the majority of the market for phage therapy in the region.

The market has reputed players across the globe with massive investment in clinical trials/ R&D activities. Clinical trial/product development companies in the market form strategic alliances with key pharmaceutical vendors to seek investment and tap potential markets in upcoming forecast years. Strategic alliances with contract manufacturers, the scientific community, and policymakers will enhance the development of phage therapy for clinical trials companies. The rapid increase in investment in the phage industry has been seen in recent years due to significant market opportunities in upcoming years.
The global phage therapy market is segmented on the basis of product, application, and region. Based on the products, the market is divided into oral, external application, and surgical treatment. On the basis of application type, the market is segmented into Human Medicine, Veterinary Science, and Others (Agriculture, dentistry, etc.). Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
The key players of this market include Armata Pharmaceuticals, Inc., Adaptive Phage Therapeutics, AmpliPhi Biosciences, BiomX (MBcure Ltd.), C3J Therapeutics, Enbiotix, Eligo Bioscience, Intralytix, Inc., InnoPhage, iNtODEWorld, Locus Biosciences, MicroPhage, Inc., Phage International, PhagoMed Biopharma GmbH, Pherecydes Pharma SA, TechnoPhage, Phagelux, SNIPR BIOME, and Microgen Russia.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Phage Therapy Market Snapshot

Chapter 4. Global Phage Therapy Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Penetration & Growth Prospect Mapping

4.6. Clinical Trial/Pipeline Analysis

4.7. Industry Analysis – Porter’s Five Forces Analysis

4.8. Competitive Landscape & Market Share Analysis

4.9. Technology Advancement in Phage Therapy

4.10. Key Trends in the Market

Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2026

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2027 for the following Product:

5.2.1. Human Medicine

5.2.2. Veterinary Science

5.2.3. Others (Agriculture, dentistry, etc)

Chapter 6. Phage Therapy Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2019 & 2026

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2018 to 2027 for the following Application:

6.2.1. Human Medicine

6.2.2. Veterinary Science

6.2.3. Others (Agriculture, dentistry, etc)

Chapter 7. Phage Therapy Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by product, 2018-2027

7.1.2. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by end-user, 2018-2027

7.1.3. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by country, 2018-2027 U.S. Canada

7.2. Europe

7.2.1. Europe Phage Therapy Market revenue (US$ Million) by product, 2018-2027

7.2.2. Europe Phage Therapy Market revenue (US$ Million) by end-user, 2018-2027

7.2.3. Europe Phage Therapy Market revenue (US$ Million) by country, 2018-2027 Germany Poland France Italy Spain UK Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Phage Therapy Market revenue (US$ Million) by product, 2018-2027

7.3.2. Asia Pacific Phage Therapy Market revenue (US$ Million) by end-user, 2018-2027

7.3.3. Asia Pacific Phage Therapy Market revenue (US$ Million) by country, 2018-2027 China India Japan Australia Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Phage Therapy Market revenue (US$ Million) by product, (US$ Million)

7.4.2. Latin America Phage Therapy Market revenue (US$ Million) by end-user, (US$ Million)

7.4.3. Latin America Phage Therapy Market revenue (US$ Million) by country, (US$ Million) 2018-2027 Brazil Rest of Latin America

7.5. MEA

7.5.1. MEA revenue Phage Therapy Market revenue (US$ Million) by product, (US$ Million) 2018-2027

7.5.2. MEA revenue Phage Therapy Market revenue (US$ Million) by country, (US$ Million) 2018-2027 South Africa Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Armata Pharmaceuticals, Inc.

8.2.2. Adaptive Phage Therapeutics

8.2.3. AmpliPhi Biosciences

8.2.4. BiomX (MBcure Ltd.)

8.2.5. C3J Therapeutics

8.2.6. Enbiotix

8.2.7. Eligo Bioscience

8.2.8. Intralytix, Inc.

8.2.9. InnoPhage

8.2.10. iNtODEWorld

8.2.11. Locus Biosciences

8.2.12. MicroPhage, Inc.

8.2.13. Phage International

8.2.14. PhagoMed Biopharma GmbH

8.2.15. Pherecydes Pharma SA

8.2.16. TechnoPhage

8.2.17. Phagelux


8.2.19. Phage Technologies S.A

8.2.20. Cytophage Technologies Inc.

Microgen Russia

Global Phage Therapy Market Segmentation

Global Phage Therapy Market by Product Revenue (US$ Mn) Forecast 2019-2030

  • Oral
  • External Application
  • Surgical Treatment

Global Phage Therapy Market Based on Application Revenue (US$ Mn) Forecast 2019-2030

  • Human Medicine
  • Veterinary Science
  • Others (Agriculture, dentistry, etc)

Global Phage Therapy Market Based on Region Revenue (US$ Mn) Forecast 2019-2030

Europe Revenue (US$ Mn) Forecast 2019-2030

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Revenue (US$ Mn) Forecast 2019-2030

  • U.S.
  • Canada

Asia Pacific Revenue (US$ Mn) Forecast 2019-2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Revenue (US$ Mn) Forecast 2019-2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Revenue (US$ Mn) Forecast 2019-2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa


InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients